【progression-free_survival】什么意思_英语progression-free_survival的翻译_音标_读音_用法_例句_在线翻译

progression-free survival

无进展生存期

这项临床试验的主要终点是无进展生存期(progression-free survival)：卡博替尼的无进展生存期是中值8.2个月，而对舒尼替尼而言，这一数字是5.6个月。

基于270个网页-相关网页

无进展生存时间

...。3组的治疗均持续至患者出现疾病进展或出现无法耐受的不良反应或死亡。研究的主要终点为中位无进展生存时间(progression-free survival，PFS)和12个月PFS率，次要终点为总体缓解率、安全性/不良反应。结果：随访中A、C组各失访1例。

基于74个网页-相关网页

短语

更多收起网络短语

医药科学

·2,447,543篇论文数据，部分数据来源于NoteExpress

abstract: Progression-free survival (PFS) is the length of time during and after medication or treatment during which the disease being treated (usually cancer) does not get worse. It is sometimes used as a metric to study the health of a person with a disease to try to determine how well a new treatment is working.

以上来源于: WordNet

Median progression-free survival was 6 months.

中位无进展生存期为6个月。

youdao
In both studies, the primary efficacy endpoint was progression-free survival.

在两项研究中，主要功效评估指标是无进展生存期。

youdao
The median progression-free survival period with the drug combination was 11.8 months, twice as long as the 5.9 months achieved with paclitaxel alone.

药物联用的中值无进展存活期为11.8个月，是用单独紫杉醇获得的5.9个月的两倍。

youdao

更多双语例句

The median progression-free survival for patients receiving T-DM1 was 9.6 months, compared to 6.4 months in the group receiving Xeloda and Tykerb, a difference considered statistically significant.

WSJ: Roche Breast-Cancer Treatment Advances
In a tougher measure of efficacy that takes into account how long patients lived, called progression-free survival, Thalomid more than doubled the length of time patients lived, to 57 weeks.

FORBES: Thalomid Fuels Celgene's Rise
While the drug combo did meet the first goal of increasing progression-free survival, it failed to prolong overall survival beyond what is normal for patients on chemotherapy without Erbitux.

FORBES: Market Scan

更多权威例句

应用推荐

$firstVoiceSent

- 来自原声例句